Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Successful OCT imaging of oral cancer tissue announced by MDL and UCH


Optical imaging company Michelson Diagnostics Ltd (MDL) announced today successful initial results from clinical testing, on oral cancer tissue, of its groundbreaking OCT imaging technology by partner University College Hospital, London (UCH).

The tests, performed by UCH scientists on cancerous and suspected cancerous human oral issue, were designed to establish the potential for MDL’s optical imaging technology to revolutionize head and neck cancer diagnosis and treatment. The tests involved comparing images taken by the MDL scanner of the tissue samples, with histopathology images analyzed by trained pathologists.

'We are very excited about the breakthrough in image quality that this system offers,' said Mr Colin Hopper, Senior Maxillofacial Surgeon at UCH. He added 'OCT could revolutionise the surveillance of pre-cancers in the mouth and eliminate the waiting time for biopsy results. It should also minimise surgery through improved disease mapping. This will provide cost effective treatments with improved cure rates”.

In the tests, 25 oral tissue samples were collected from 14 patients of the UCH National Medical Laser Centre. The samples were scanned with the MDL OCT imaging system and then prepared for analysis by Pathologist Dr Brendan Conn. Clinical Research Fellow Mr Waseem Jerjes said “the histopathology results showed that it is possible to identify surface structures such as keratin and epithelial layers, the epidermal / dermal junction and areas of cellular crowding as well as any pathological changes that occurs at that level; this is very exciting, this method seems to hold great promises for early in vivo tumour diagnosis”.

The company’s highly innovative optical probe technology offers the best available sub-surface OCT images for research applications in cancer surgery guidance, surveillance and diagnosis.

…….ends…….


For further information and press enquiries contact:
Dr Gordon McKenzie, Applications Director, Tel: +44 797 3343414
Email: Gordon.McKenzie@md-ltd.co.uk

Michelson Diagnostics Ltd, 11A Grays Farm Production Village, Orpington, Kent, BR5 3BD, ULK
Web: www.michelsondiagnostics.co.uk

Michelson Diagnostics Ltd is the UK’s leading independent manufacturer and developer of Optical Coherence Tomography medical imaging equipment. Founded in 2006, it is based in SE London, UK. The company’s highly innovative optical probe technology offers the best available sub-surface OCT images for cancer surgery guidance, surveillance and diagnostic applications.


Publisher Contact Information:

Michelson Diagnostics
020 7558 8406
adrienne.harris@md-ltd.co.uk

Company profile of Michelson Diagnostics
Past press releases of Michelson Diagnostics.

Data


26,231
Tech investments
From our Online Data Service
16,945
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.